26 Mar 2026
Information Disclosure and Peer Innovation: Evidence from Mandatory Reporting of Clinical Trials
In 2007, the U.S. Food and Drug Administration Amendments Act (FDAAA) required pharmaceutical companies to publicly disclose the entire process of their clinical trials, including trial design, sample size, progress milestones, and final results, covering both successes and failures. This reform made the previously opaque FDA process more transparent, providing peers with unprecedented sources of information....